747 filings
Page 6 of 38
DEFA14A
flcdg86km
11 Oct 22
Additional proxy soliciting materials
5:23pm
DFAN14A
u3cqz2to
11 Oct 22
Additional proxy materials by non-management
4:33pm
8-K
cwrt5aft4kw
19 Aug 22
Amarin Provides Update on VAZKEPA® (icosapent ethyl) Pricing Negotiations in Germany
4:31pm
S-8
zyqn1c6
5 Aug 22
Registration of securities for employees
5:17pm
8-K
ahhat1 e9bl2
3 Aug 22
Amarin Reports Second Quarter 2022 Financial Results and Provides Business Update
7:08am
8-K
er99iusn
30 Jun 22
Departure of Directors or Certain Officers
5:20pm
DEFA14A
4e0jk59yldn3
17 Jun 22
Additional proxy soliciting materials
4:52pm
8-K
ru42vko7u nldj
6 Jun 22
Amarin Announces Comprehensive Cost Reduction Plan to Address Market Dynamics In U.S. Business
4:36pm
8-K
93d lod0u6t
20 May 22
Amarin Announces Appointment of New Directors and Board Leadership Changes
7:47am
8-K
nz8ut
4 May 22
Amarin Reports First Quarter 2022 Financial Results and Provides Business Update
7:09am
8-K
5b3dyy0
1 Mar 22
Amarin Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
6:07am
8-K
ruq4 b3g5
10 Jan 22
Amarin Provides Preliminary 2021 Revenue and Outlook for 2022
9:06am
8-K
ze9tkg
3 Nov 21
Amarin Reports Third Quarter 2021 Financial Results and Provides Business Update
6:06am
8-K
iotgr5z4i9wrp
27 Sep 21
Enables Amarin to Drive Additional Demand, Improve Patient Access & Education and Secure Proper Fulfillment and Reimbursement
8:30am